register

Sales

How ultra-high performers leverage sales-specific emotional intelligence to close

Health Industry Hub | May 3, 2019 |
[Total: 1    Average: 5/5]

Being a salesperson today isn’t easy. Thanks to the Internet and other high-tech advances, buyers have more tools, product knowledge and purchasing power than ever. Technology makes it easy for an army of “me-too competitors” to enter your market. These new firms and their goods or services make product and pricing differentiation a challenge for longestablished companies and their salespeople.

Sales EQ can be your competitive edge. Busy customers with short attention spans don’t want “kitchen-sink data dumps of features and benefits and canned product pitches.” Today’s customers crave “authentic human interaction.”


Human Resources

PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals

Health Industry Hub | January 17, 2022 |

Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]

More


News & Trends - Medical Technology

MedTech News -

Stryker announces fellowships for medtech partner projects

Health Industry Hub | January 17, 2022 |

MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]

More


News & Trends - Pharmaceuticals

Pharma News - New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

Health Industry Hub | January 17, 2022 |

Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]

More


News & Trends - Pharmaceuticals

Pharma News -

Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma

Health Industry Hub | January 17, 2022 |

Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]

More